OOIR: Observatory of International Research

Papers

(The TQCC of Cancer Journal is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Human Papillomavirus–Directed Therapeutics for Human Papillomavirus–Associated Oropharyngeal Cancer	49
Theranostics in Neuroendocrine Tumors	41
Hepatocellular Carcinoma Genetic Classification	31
Improving Equity in Cancer Care in the Face of a Public Health Emergency	19
Adoptive Cell Therapy for Advanced Solid Tumors	18
Concerns About Compounded Bioidentical Menopausal Hormone Therapy	15
Poly(ADP-Ribose) Polymerase Inhibition in Small Cell Lung Cancer	14
Beyond the COVID-19 Pandemic	14
Is There a Role for Cellular Therapy in Chronic Lymphocytic Leukemia?	14
Menopausal Hormone Therapy and Breast Cancer	14
Circulating Biomarkers in Glioblastoma	13
Autoimmune Cytopenia in CLL	13
Minimal Residual Disease in Multiple Myeloma	12
Cell Cycle Checkpoints p16 and p21—Strong Predictors of Clinicopathologic Outcomes in High-Grade Osteosarcoma	12
The Clinical Value of Plasma Epstein-Barr Virus DNA as a Tumor Marker in Nasopharyngeal Carcinoma: Prognostic? Yes, But How Can We Best Use It?	11
The Clinical Challenges, Trials, and Errors of Combatting Poly(ADP-Ribose) Polymerase Inhibitors Resistance	11
New Roles of Poly(ADP-Ribose) Polymerase Inhibitors in the Treatment of Breast Cancer	11
Oncology Physician Workforce Diversity	10
The Potential for Selective Cyclin-Dependent Kinase 4/6 Inhibition in the Therapy for Head and Neck Squamous Cell Carcinoma	10
Disparities in Gynecologic Cancers	9
Is There a Current Role for Combination Chemotherapy or High-Dose Interleukin 2 in Melanoma?	9
PET Imaging of Metabolism, Perfusion, and Hypoxia	8
Toxicities From Antibody-Drug Conjugates	7
Chimeric Antigen Receptor T-Cell Therapy	7
Social Drivers of Cancer Risk and Outcomes Among African American Men	7

Updates in Classification of Myelodysplastic Syndrome	7
Evolution of Response-Based Radiotherapy for Hepatocellular Cancer	7
Targeting Epidermal Growth Factor Receptor in Head and Neck Cancer	7
Hepatocellular Carcinoma—Southeast Asia Updates	7
HER2 and HER3 as Therapeutic Targets in Head and Neck Cancer	7
Microbiome and Diet in Colon Cancer Development and Treatment	7
Supportive Care for Patients With Myelodysplastic Syndromes	7
Treatment of Locally Recurrent Rectal Cancer	6
Effective Personalization of Stereotactic Radiosurgery for Brain Metastases in the Modern Era	6
Introduction	6
Poly(ADP-Ribose) Polymerase Inhibitor Inhibition in Ovarian Cancer	6
Digital Health for Oncological Care	6
New Metabolomic Insights Into Cancer	6
Radiopharmaceuticals for Cancer Diagnosis and Therapy	6
Mechanistic Effects of Estrogens on Breast Cancer	6
Impact of Precision Medicine in Oncology	6
Epidemiology and Pathogenesis of Myelodysplastic Syndrome	6
Ecosystemic Approach to Understanding Gut Microbiome–Mediated Prevention of Colorectal Cancer	6
Radiation Therapy and the Microbiome; More Than a Gut Feeling	6
From Bench to Bedside	6
The Current Role of Human Papillomavirus Circulating Tumor DNA in Oropharynx Cancer	6
Individualizing Therapy for Malignant Gliomas	5
Health Care Policy and Disparities in Health	5
A General Approach to Patients Presenting With Locally Advanced or Distant Metastatic Disease	5
The Evolution of Research and Therapy With Hypomethylating Agents in Acute Myeloid Leukemia and Myelodysplastic Syndrome: New Directions for Old Drugs	5
Telehealth in Cancer Care	5
How Far We’ve Come	5
Local and Systemic Management Options for Melanoma Brain Metastases	5
Targeting HRAS in Head and Neck Cancer	5
Building a Bridge to Equity in Health and Health Care in Cancer Care	5
Myelodysplastic Syndromes/Neoplasms—Insights Into Pathogenesis Leading to Improved Classification, Risk Stratification, and Treatments	5
Telehealth and Technology	5
Circulating Tumor DNA in Human Papillomavirus–Mediated Oropharynx Cancer	5
Clinical Evidence Generation During a Pandemic	4
Management of Chronic Lymphocytic Leukemia in Less-Resourced Countries	4
Evolution of Therapy for Older Patients With Acute Myeloid Leukemia	4
Adoptive Cellular Therapy for Pediatric Solid Tumors: Beyond Chimeric Antigen Receptor-T Cell Therapy	4
Introduction Chronic Lymphocytic Leukemia. Where Do We Stand, Where Do We Go	4
Evolving Landscape of Antibody Drug Conjugates in Lymphoma	4
Role of the Microbiome in Immunotherapy of Melanoma	4
Short- and Long-term Repercussions of Vancomycin on Immune Surveillance and the Efficacy of Antitumor Treatments	4
An Overview of Organoid and 3-Dimensional Models in Multiple Myeloma	4